Skip to main content
. 2017 Jan 27;8(12):18914–18923. doi: 10.18632/oncotarget.14835

Figure 5. IL-17B activates the NF-κΒ, STAT3, β-catenin pathway of MSCs.

Figure 5

(A and B) The expressions of total and phosphorylated NF-κΒ, STAT3 and β-catenin were determined by western blot analyses of hucMSCs (A) and GC-MSCs (B) treated with corresponding concentrations of rIL-17B.